Gout incidence rate significantly reduced with SGLT2 inhibitor vs GLP-1 receptor agonist.
Researchers have found that tofacitinib, a drug approved by the FDA to treat rheumatoid arthritis and ulcerative colitis, might also treat leaky gut.
In addition to a panel of experts, for the first time, the guideline was developed with the help of patients, emphasizing the importance of shared decision-making.
Study researchers aimed to identify undiagnosed cases of arthropathy of Down syndrome (A-DS), time to diagnosis, and clinical, laboratory and radiologic features of A-DS at diagnosis.
Resistance exercise alone or in combination with aerobic exercise was found to be better than aerobic exercise alone in reducing weight loss-induced decreases in hip BMD.
This study evaluated previously unreported data from the NHANES 2009-2010 and NHANES 2 (1976-1980) questionnaires that were used to compare axial pain rates among patients with and without inflammatory bowel disease.
Elevated calcium levels may lead to suboptimal growth of bone, according to the study’s findings.
Patients with new-onset low back pain who initially consulted a chiropractor or physical therapist vs a primary care physician were found to have reduced risk for long-term opioid use.
Gout more than doubles the risk for end-stage kidney disease.
Findings show a dose- or frequency-dependent association; all antibiotic classes linked to higher odds for RA.
Older pubertal age was associated with lower BMD in adolescence and early adulthood, despite some catch-up during puberty.
Considerable proportion of increased CHF, IHD, and stroke risk mediated by NSAID use.
Findings indicated by perivascular fat attenuation index, as measured by coronary CT angiography.
Researchers aimed to assess the association between height and weight velocities across different age periods with bone measures at age 7 years.
Self-administered acupressure may be efficacious for reducing pain and fatigue in patients with chronic low back pain.
Increased incidences found for lymphoma, lung cancer (in male patients), and cervical cancer.
However, sleep disorder does not lessen the impact of pain intensity, disability on health care utilization.
Treatment with anti-TNFα agents for conditions other than inflammatory bowel disease may increase the risk of developing Crohn disease or ulcerative colitis.
Even 2 years of clinical remission does not protect against bone erosions.
Mortality decrease greater in systemic lupus erythematosus pregnancies than in non-SLE pregnancies.